Overview

During this presentation, we will discuss the current unmet needs in migraine diagnosis and individualized treatment, highlighting the role of the CGRP pathway in migraine pathophysiology and how inhibition of this pathway may help reduce symptoms and frequency of migraine attacks. We will review new clinical data and patient cases that showcase how CGRP receptor antagonists may be used to help meet treatment needs across a broad range of patients.

SPONSORED BY

Pfizer, Inc.